We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
A review on poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) [P(3HB-co-3HHx)] and genetic modifications that affect its production
Summary
This review examined the properties, biodegradation behavior, and application potential of the biopolymer P(3HB-co-3HHx), a polyhydroxyalkanoate with mechanical properties comparable to common commodity plastics. The authors assess its viability as a drop-in replacement for single-use plastics, medical devices, and packaging with genuine end-of-life biodegradability.
Polyhydroxyalkanoates (PHAs) have garnered global attention to replace petroleum-based plastics in certain applications due to their biodegradability and sustainability. Among the different types of PHAs, poly(3-hydroxybutyrate-<i>co</i>-3-hydroxyhexanoate) [P(3HB-<i>co</i>-3HHx)] copolymer has similar properties to commodity plastics, making them a suitable candidate to replace certain types of single-use plastics, medical devices, and packaging materials. The degradation rate of P(3HB-<i>co</i>-3HHx) is faster than the commercial petroleum-based plastics which take a very long time to be degraded, causing harmful pollution to both land and marine ecosystem. The biodegradability of the P(3HB-<i>co</i>-3HHx) is also dependent on its 3HHx molar composition which in turn influences the crystallinity of the material. Various metabolic pathways like the common PHA biosynthesis pathway, which involves <i>phaA, phaB,</i> and <i>phaC</i>, β-oxidation, and fatty acids <i>de novo</i> synthesis are used by bacteria to produce PHA from different carbon sources like fatty acids and sugars, respectively. There are various factors affecting the 3HHx molar composition of P(3HB-<i>co</i>-3HHx), like PhaCs, the engineering of PhaCs, and the metabolic engineering of strains. It is crucial to control the 3HHx molar composition in the P(3HB-<i>co</i>-3HHx) as it will affect its properties and applications in different fields.
Sign in to start a discussion.